Patrick M. Siegel

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells

Patrick M. Siegel, Laura Sander, Alba Fricke et al. · Scientific Reports · 2021 · 64 citations · Full text

Medicine, Cardiology, Pharmacology +17

Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability

Philipp Diehl, Frederik Nienaber, Maria T. K. Zaldivia et al. · Thrombosis and Haemostasis · 2019 · 63 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Cross-species single-cell RNA sequencing reveals divergent phenotypes and activation states of adaptive immunity in human carotid and experimental murine atherosclerosis

Hauke Horstmann, Nathaly Anto Michel, Xia Sheng et al. · Cardiovascular Research · 2024 · 26 citations · Full text

Life Sciences, Cardiology, Immunology +15

Early platelet dysfunction in patients receiving extracorporeal membrane oxygenation is associated with mortality

Patrick M. Siegel, Julia Chalupsky, Christoph B. Olivier et al. · Journal of Thrombosis and Thrombolysis · 2021 · 24 citations · Full text

Medicine, Cardiology, Hematology +17

A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction

Patrick M. Siegel, István Bojti, Nicole Bassler et al. · Basic Research in Cardiology · 2021 · 19 citations · Full text

Veterinary Medicine, Cell Biology, Immunology +17